Katharina König

2.1k total citations
20 papers, 1.0k citations indexed

About

Katharina König is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Katharina König has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Katharina König's work include Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Katharina König is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). Katharina König collaborates with scholars based in Germany, United States and Switzerland. Katharina König's co-authors include Lukas C. Heukamp, Sabine Merkelbach‐Bruse, Reinhard Büttner, Reinhard Buettner, Lydia Meder, Jana Fassunke, Michaela A. Ihle, Hans‐Ulrich Schildhaus, Jürgen Wolf and Inga Grünewald and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Katharina König

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina König Germany 14 564 357 246 231 121 20 1.0k
Francesco Atzori Italy 13 776 1.4× 435 1.2× 219 0.9× 270 1.2× 145 1.2× 62 1.4k
Françoise Descôtes France 20 593 1.1× 342 1.0× 326 1.3× 154 0.7× 247 2.0× 66 1.2k
Mary Matli United States 13 806 1.4× 431 1.2× 424 1.7× 160 0.7× 90 0.7× 20 1.3k
Susan J. Hsiao United States 18 615 1.1× 444 1.2× 208 0.8× 208 0.9× 130 1.1× 49 1.3k
A. W. Tolcher United States 19 821 1.5× 583 1.6× 201 0.8× 310 1.3× 43 0.4× 107 1.3k
Francesco Merolla Italy 25 845 1.5× 486 1.4× 209 0.8× 247 1.1× 88 0.7× 66 1.3k
Graham H.P. Richmond United Kingdom 5 492 0.9× 473 1.3× 175 0.7× 321 1.4× 46 0.4× 6 947
Nikita Makretsov Canada 14 682 1.2× 593 1.7× 380 1.5× 164 0.7× 90 0.7× 19 1.4k
Karin Wadt Denmark 18 701 1.2× 528 1.5× 319 1.3× 133 0.6× 147 1.2× 65 1.4k
Roger Mouawad France 21 523 0.9× 308 0.9× 177 0.7× 155 0.7× 121 1.0× 57 968

Countries citing papers authored by Katharina König

Since Specialization
Citations

This map shows the geographic impact of Katharina König's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina König with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina König more than expected).

Fields of papers citing papers by Katharina König

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina König. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina König. The network helps show where Katharina König may publish in the future.

Co-authorship network of co-authors of Katharina König

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina König. A scholar is included among the top collaborators of Katharina König based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina König. Katharina König is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meder, Lydia, Katharina König, Felix Dietlein, et al.. (2018). LIN28B enhanced tumorigenesis in an autochthonous KRASG12V-driven lung carcinoma mouse model. Oncogene. 37(20). 2746–2756. 18 indexed citations
2.
Tiedje, Vera, Katharina König, Saskia Ting, et al.. (2016). Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine. 54(3). 733–741. 44 indexed citations
3.
Meder, Lydia, Katharina König, Luka Ozretić, et al.. (2015). NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. International Journal of Cancer. 138(4). 927–938. 141 indexed citations
4.
5.
Meder, Lydia, Katharina König, Jana Fassunke, et al.. (2015). Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases. Experimental and Molecular Pathology. 99(3). 682–686. 8 indexed citations
6.
Gautschi, Oliver, Katharina König, Reinhard Büttner, et al.. (2015). Mutation Profiling of Lung Cancers with Long-Term Response to Gefitinib Therapy. Oncology Research and Treatment. 38(11). 560–569. 5 indexed citations
7.
Schöttle, Jakob, Sampurna Chatterjee, Alexandra Florin, et al.. (2015). Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget. 6(36). 38458–38468. 16 indexed citations
8.
9.
Elbelt, Ulf, Alessia Trovato, Michael Kloth, et al.. (2014). Molecular and Clinical Evidence for anARMC5Tumor Syndrome: Concurrent Inactivating Germline and Somatic Mutations Are Associated With Both Primary Macronodular Adrenal Hyperplasia and Meningioma. The Journal of Clinical Endocrinology & Metabolism. 100(1). E119–E128. 73 indexed citations
10.
Fuchs, Ângela, Katharina König, Lukas C. Heukamp, et al.. (2014). Tuberous-sclerosis complex-related cell signaling in the pathogenesis of lung cancer. Diagnostic Pathology. 9(1). 48–48. 6 indexed citations
11.
Heydt, Carina, Jana Fassunke, Helen Künstlinger, et al.. (2014). Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics. PLoS ONE. 9(8). e104566–e104566. 40 indexed citations
12.
Eisert, Anna, Matthias Scheffler, Sebastian Michels, et al.. (2014). Genetic Variability and Clinical Presentation of Patients with Non-Small Cell Lung Cancer (Nsclc) Harboring Met-Amplifications. Annals of Oncology. 25. iv463–iv463. 1 indexed citations
13.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(4). 1732–1740. 164 indexed citations
14.
Vollbrecht, Claudia, et al.. (2013). Molekularpathologie der Lunge. Der Pathologe. 34(1). 16–24. 2 indexed citations
15.
König, Katharina, Lydia Meder, Cornelia Kröger, et al.. (2013). Loss of the Keratin Cytoskeleton Is Not Sufficient to Induce Epithelial Mesenchymal Transition in a Novel KRAS Driven Sporadic Lung Cancer Mouse Model. PLoS ONE. 8(3). e57996–e57996. 24 indexed citations
16.
Chatterjee, Sampurna, Lukas C. Heukamp, Jakob Schöttle, et al.. (2013). Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation. 123(7). 3183–3183. 15 indexed citations
17.
Sprüssel, Annika, Johannes H. Schulte, Susanne N. Weber, et al.. (2012). Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia. 26(9). 2039–2051. 156 indexed citations
18.
Bill, Anke, Anton Schmitz, Katharina König, et al.. (2012). Anti-Proliferative Effect of Cytohesin Inhibition in Gefitinib-Resistant Lung Cancer Cells. PLoS ONE. 7(7). e41179–e41179. 29 indexed citations
19.
Baisch, H., Ulrich Otto, Katharina König, et al.. (1982). DNA content of human kidney carcinoma cells in relation to histological grading. British Journal of Cancer. 45(6). 878–886. 68 indexed citations
20.
SCHAEFER, H., et al.. (1961). Über die Chromoproteidausscheidung der Niere, insbesondere nach Starkstromunfall, und die Alkalitherapie. Research in Experimental Medicine. 135(2). 83–166. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Atzori Breakdown of academic impact, for papers by Françoise Descôtes Breakdown of academic impact, for papers by Mary Matli Breakdown of academic impact, for papers by Susan J. Hsiao Breakdown of academic impact, for papers by A. W. Tolcher Breakdown of academic impact, for papers by Francesco Merolla Breakdown of academic impact, for papers by Graham H.P. Richmond Breakdown of academic impact, for papers by Nikita Makretsov Breakdown of academic impact, for papers by Karin Wadt Breakdown of academic impact, for papers by Roger Mouawad
Rankless by CCL
2026